Division of Gastroenterology, VA New York Harbor Healthcare System and New York, University School of Medicine, New York, NY, USA.
J Subst Abuse Treat. 2012 Jun;42(4):438-45. doi: 10.1016/j.jsat.2011.09.007. Epub 2011 Oct 27.
Although substance abuse treatment programs are important contact points for providing health services for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, availability of services in these programs has not been well characterized. This study evaluated the spectrum of HBV and HCV services offered by substance abuse treatment programs within the National Drug Abuse Treatment Clinical Trials Network. Our survey of substance abuse treatment program administrators covered availability of testing for HBV and HCV; hepatitis A virus (HAV) and HBV immunization; and HCV medical and nonmedical services. There were also questions covering clarity of guidelines for HBV and HCV testing and HAV and HBV immunization. Differences between methadone and nonmethadone programs were examined. Despite the importance of substance abuse in sustaining the hepatitis epidemics, few programs offer comprehensive HBV and HCV testing or HCV health care services. Interventions to improve access to hepatitis services for substance-abusing patients are needed.
虽然药物滥用治疗项目是为乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染提供医疗服务的重要接触点,但这些项目中提供的服务情况尚未得到很好的描述。本研究评估了国家药物滥用治疗临床试验网络内药物滥用治疗项目提供的 HBV 和 HCV 服务范围。我们对药物滥用治疗项目管理人员进行的调查涵盖了 HBV 和 HCV 检测、甲型肝炎病毒(HAV)和 HBV 疫苗接种以及 HCV 医疗和非医疗服务的情况。还包括了有关 HBV 和 HCV 检测以及 HAV 和 HBV 疫苗接种指南清晰度的问题。对美沙酮和非美沙酮项目之间的差异进行了研究。尽管药物滥用在维持肝炎流行方面很重要,但很少有项目提供全面的 HBV 和 HCV 检测或 HCV 保健服务。需要采取干预措施,为药物滥用患者提供更多的肝炎服务。